Serca Pharmaceuticals
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$3.71M
Company Overview
Serca Pharmaceuticals operates in Healthcare & Life Sciences and is based in Oslo. Its latest recorded funding round was a Grant round in January 2025.
Serca Pharmaceuticals is a biopharmaceutical company developing a novel cardioprotective drug candidate, 13-M, for the treatment of acute myocardial infarction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serca Pharmaceuticals Comparables
Compare Serca Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orio Therapeutics SA | 85% | |
| Forcefield Therapeutics | 81% | |
| Infensa Bioscience | 79% |
For institutional investors. Book with your work email.
Serca Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Grant | Oct 1, 2020 | ||||
| VC Round | Jul 1, 2019 |
For institutional investors. Book with your work email.
Serca Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Inven2 | VC Round |
| Sarsia | VC Round |
| The Research Council of Norway | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2025
Monthly visitors increased 80% MoM.
- Oct 19, 2024
Grew 400% QoQ from 1 to 5 employees.
For institutional investors. Book with your work email.
Serca Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Serca Pharmaceuticals's valuation, stock price, and market status.
Is Serca Pharmaceuticals a public or private company?
Serca Pharmaceuticals is a private company.
What is the current stock price of Serca Pharmaceuticals?
Serca Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Serca Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Serca Pharmaceuticals worth (valuation)?
Valuation information for Serca Pharmaceuticals is not publicly available.
Can I buy Serca Pharmaceuticals stock?
Serca Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Serca Pharmaceuticals's last funding round?
Serca Pharmaceuticals's most recent funding round was Grant on January 1, 2025.
Who are the main investors in Serca Pharmaceuticals?
Key investors in Serca Pharmaceuticals include Inven2, Sarsia, The Research Council of Norway.
Will Serca Pharmaceuticals IPO soon?
No public IPO plans have been announced for Serca Pharmaceuticals.
How can I track Serca Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Serca Pharmaceuticals's shares on secondary markets.